Total Payments
$2,573
2022 Payments
$91.49
Companies
22
Transactions
106
Medicare Patients
8,357
Medicare Billing
$506,274
Payment Breakdown by Category
Food & Beverage$2,514 (97.7%)
Education$59.65 (2.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,514 | 103 | 97.7% |
| Education | $59.65 | 3 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $869.64 | 43 | $0 (2019) |
| Boston Scientific Corporation | $333.24 | 7 | $0 (2022) |
| Dendreon Pharmaceuticals LLC | $276.52 | 6 | $0 (2019) |
| AbbVie, Inc. | $218.37 | 13 | $0 (2019) |
| Allergan Inc. | $138.17 | 4 | $0 (2019) |
| C. R. Bard, Inc. & Subsidiaries | $135.00 | 1 | $0 (2017) |
| Amgen Inc. | $126.63 | 2 | $0 (2017) |
| PFIZER INC. | $77.15 | 5 | $0 (2019) |
| AMAG Pharmaceuticals, Inc. | $59.65 | 3 | $0 (2019) |
| Blue Earth Diagnostics Limited | $58.15 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $91.49 | 1 | Boston Scientific Corporation ($91.49) |
| 2019 | $381.39 | 22 | AbbVie, Inc. ($79.72) |
| 2018 | $599.14 | 27 | Astellas Pharma US Inc ($279.17) |
| 2017 | $1,501 | 56 | Astellas Pharma US Inc ($522.07) |
All Payment Transactions
106 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/03/2022 | Boston Scientific Corporation | rezum Generator (Device) | Food and Beverage | In-kind items and services | $91.49 | General |
| Category: rezum_URO | ||||||
| 10/27/2019 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: ONCOLOGY | ||||||
| 10/21/2019 | Mission Pharmacal Company | Uribel (Drug) | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: Analgesic, antispasmodic & antiseptic (urinary) | ||||||
| 10/09/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: UROLOGY | ||||||
| 09/25/2019 | Allergan Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.02 | General |
| Category: HYPERHYDROSIS | ||||||
| 09/24/2019 | Metuchen Pharmaceuticals | Stendra (Drug) | Food and Beverage | Cash or cash equivalent | $22.66 | General |
| Category: Erectile Dysfunction | ||||||
| 09/13/2019 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 08/28/2019 | AMAG Pharmaceuticals, Inc. | INTRAROSA (Drug) | Education | In-kind items and services | $16.26 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 08/13/2019 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: ONCOLOGY | ||||||
| 08/13/2019 | Aytu BioScience, Inc | Natesto (Drug) | Food and Beverage | Cash or cash equivalent | $14.25 | General |
| Category: Urology | ||||||
| 08/07/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: UROLOGY | ||||||
| 08/01/2019 | Boston Scientific Corporation | GENERAL BPH (Device) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: BPH | ||||||
| 07/30/2019 | AbbVie, Inc. | Lupron Depot (Drug) | Food and Beverage | In-kind items and services | $23.93 | General |
| Category: Endocrinology | ||||||
| 07/16/2019 | Retrophin, Inc. | (815) Thiola (Drug) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: Kidney Stones | ||||||
| 05/31/2019 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: ONCOLOGY | ||||||
| 05/15/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: Oncology | ||||||
| 04/30/2019 | AbbVie, Inc. | Lupron Depot (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Endocrinology | ||||||
| 04/26/2019 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: ONCOLOGY | ||||||
| 03/21/2019 | AbbVie, Inc. | Lupron Depot (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Endocrinology | ||||||
| 02/28/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Oncology | ||||||
| 02/25/2019 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: ONCOLOGY | ||||||
| 02/20/2019 | Blue Earth Diagnostics Limited | Axumin (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: Diagnostic Imaging | ||||||
| 01/16/2019 | AbbVie, Inc. | Lupron Depot (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Endocrinology | ||||||
| 12/11/2018 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: UROLOGY | ||||||
| 11/27/2018 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 2,042 | 2,978 | $506,088 | $119,260 |
| 2022 | 17 | 2,129 | 3,136 | $569,229 | $133,018 |
| 2021 | 20 | 2,278 | 3,228 | $611,275 | $143,006 |
| 2020 | 18 | 1,908 | 2,526 | $465,726 | $110,990 |
Total Patients
8,357
Total Services
11,868
Medicare Billing
$506,274
Procedure Codes
68
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 340 | 456 | $142,833 | $37,227 | 26.1% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 20 | 185 | $131,063 | $24,777 | 18.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 273 | 327 | $69,504 | $19,167 | 27.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 77 | 77 | $36,870 | $8,392 | 22.8% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 37 | 48 | $22,925 | $7,847 | 34.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 70 | 70 | $21,979 | $5,106 | 23.2% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 481 | 686 | $37,559 | $4,977 | 13.3% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 19 | 94 | $17,117 | $3,907 | 22.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 18 | $7,601 | $2,323 | 30.6% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 23 | 31 | $6,537 | $1,796 | 27.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 540 | 814 | $7,521 | $1,773 | 23.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 124 | 136 | $1,224 | $1,134 | 92.6% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 21 | 36 | $3,356 | $835.20 | 24.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 282 | 399 | $124,979 | $35,258 | 28.2% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 23 | 221 | $156,567 | $30,166 | 19.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 314 | 366 | $77,793 | $20,100 | 25.8% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 38 | 49 | $23,402 | $8,042 | 34.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 71 | 71 | $33,997 | $7,628 | 22.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 74 | 74 | $23,235 | $5,207 | 22.4% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2022 | 30 | 120 | $21,852 | $4,912 | 22.5% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 463 | 644 | $35,259 | $4,547 | 12.9% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2022 | 14 | 16 | $20,160 | $4,481 | 22.2% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2022 | 13 | 13 | $9,263 | $3,033 | 32.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 22 | 22 | $9,290 | $2,922 | 31.4% |
| 81003 | Automated urinalysis test | Office | 2022 | 550 | 837 | $7,734 | $1,837 | 23.8% |
About Dr. David Pinkstaff, MD
Dr. David Pinkstaff, MD is a Specialist healthcare provider based in Gatesville, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013020486.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Pinkstaff, MD has received a total of $2,573 in payments from pharmaceutical and medical device companies, with $91.49 received in 2022. These payments were reported across 106 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($2,514).
As a Medicare-enrolled provider, Pinkstaff has provided services to 8,357 Medicare beneficiaries, totaling 11,868 services with total Medicare billing of $506,274. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Urology
- Location Gatesville, TX
- Active Since 08/17/2006
- Last Updated 06/03/2025
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1013020486
Products in Payments
- Myrbetriq (Drug) $442.60
- XTANDI (Drug) $318.51
- PROVENGE (Drug) $299.46
- MYRBETRIQ (Drug) $152.12
- BMD-Bard Skylite (Device) $135.00
- BOTOX (Biological) $114.38
- AMS 700 (Device) $111.11
- XGEVA (Biological) $107.05
- GENERAL - THERAPIES (Device) $104.72
- rezum Generator (Device) $91.49
- Lupron Depot (Drug) $79.72
- Xtandi (Drug) $79.47
- Androgel (Drug) $70.06
- Lupron (Drug) $68.59
- INTRAROSA (Drug) $59.65
- Axumin (Drug) $58.15
- Erleada (Drug) $33.59
- XIAFLEX (Biological) $30.03
- ELIGARD (Drug) $29.84
- BOTOX THERAPEUTIC (Biological) $23.79
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.